CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathwaysKiyoko Nakamura, Masahide Ohmichi, Yoshito Terai et al.|Oncology Reports|2017Cited by 117
The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancerMasaaki Takai, Masahide Ohmichi, Yoshito Terai et al.|Journal of Ovarian Research|2014Cited by 108
GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancerSatoe Fujiwara, Masahide Ohmichi, Yoshito Terai et al.|Journal of Ovarian Research|2012Cited by 79
Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancerKazuya Maeda, Masahide Ohmichi, Hiroshi Sasaki et al.|Journal of Ovarian Research|2020Cited by 59
Comparison of the Perinatal Outcomes after Laparoscopic Myomectomy versus Abdominal MyomectomyMamiko Fukuda, Masahide Ohmichi, Tomohito Tanaka et al.|Gynecologic and Obstetric Investigation|2013Cited by 59